Insider Trading & Ownership of James Darecca
-
Location
-
Boston, MA
-
Summary
-
The estimated net worth of James Darecca is at least $4,338,484 dollars as of 06 Aug 2025. James Darecca is the EVP, Chief Financial Officer of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $1.96M. James Darecca is the Chief Financial Officer of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $1.86M. James Darecca is the Director of Prestige Consumer Healthcare Inc. and owns shares of Prestige Consumer Healthcare Inc. (PBH) stock worth about $518.2K.
-
Signature
-
/s/ James C. D'Arecca by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated July 5, 2023 on file with the Commission
Follow Filing Activity
Follow James Darecca and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- James Darecca has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,338,484.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: HAEMONETICS CORP ($1,962,898).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of James Darecca
Insider Transactions Reported by James Darecca:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.